Page last updated: 2024-10-21

3-aminobenzamide and Cirrhosis

3-aminobenzamide has been researched along with Cirrhosis in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Fibrosis is one of the major pathological features of hypertensive vascular disease."5.39Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats. ( Deng, S; Huang, D; Huang, K; Wang, L; Wang, R; Wang, Y; Zhang, C; Zhang, F; Zhang, Y, 2013)
"Fibrosis is one of the major pathological features of hypertensive vascular disease."1.39Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats. ( Deng, S; Huang, D; Huang, K; Wang, L; Wang, R; Wang, Y; Zhang, C; Zhang, F; Zhang, Y, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Y1
Wang, L1
Zhang, F1
Zhang, C1
Deng, S1
Wang, R1
Zhang, Y1
Huang, D1
Huang, K1

Other Studies

1 other study available for 3-aminobenzamide and Cirrhosis

ArticleYear
Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats.
    International journal of cardiology, 2013, Sep-01, Volume: 167, Issue:5

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Benzamides; Cells, Cultured; Enzyme Inhibitors; Fibrosis;

2013